Literature DB >> 9856464

Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse.

F Nakamura1, M Tanaka, T Takahashi, R G Kalb, S M Strittmatter.   

Abstract

Somatosensory axon outgrowth is repulsed when soluble semaphorin D (semD) binds to growth cone neuropilin-1 (Npn-1). Here, semD ligand binding studies of Npn-1 mutants demonstrate that the sema domain binds to the amino-terminal quarter, or complement-binding (CUB) domain, of Npn-1. By herpes simplex virus- (HSV-) mediated expression of Npn-1 mutants in chick retinal ganglion cells, we show that semD-induced growth cone collapse requires two segments of the ectodomain of Npn-1, the CUB domain and the juxtamembrane portion, or MAM (meprin, A5, mu) domain. In contrast, the transmembrane segment and cytoplasmic tail of Npn-1 are not required for biologic activity. These data imply that the CUB and MAM ectodomains of Npn-1 interact with another transmembrane growth cone protein that in turn transduces a semD signal into axon repulsion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856464     DOI: 10.1016/s0896-6273(00)80626-1

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  72 in total

1.  Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.

Authors:  Alyson E Fournier; Graham C Gould; Betty P Liu; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth.

Authors:  Katsuhisa Tanabe; Iris Bonilla; Jeffrey A Winkles; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2003-10-22       Impact factor: 6.167

3.  The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.

Authors:  Janet L Fisher
Journal:  Neuropharmacology       Date:  2015-08-13       Impact factor: 5.250

4.  Plexina2 and CRMP2 Signaling Complex Is Activated by Nogo-A-Liganded Ngr1 to Restrict Corticospinal Axon Sprouting after Trauma.

Authors:  Yuichi Sekine; Percy T Algarate; William B J Cafferty; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2019-02-25       Impact factor: 6.167

Review 5.  ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases.

Authors:  André Schmandke; Antonio Schmandke; Stephen M Strittmatter
Journal:  Neuroscientist       Date:  2007-10       Impact factor: 7.519

6.  Release of MICAL autoinhibition by semaphorin-plexin signaling promotes interaction with collapsin response mediator protein.

Authors:  Eric F Schmidt; Sang-Ohk Shim; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

7.  Differential expression of class 3 and 4 semaphorins and netrin in the lamprey spinal cord during regeneration.

Authors:  Michael I Shifman; Michael E Selzer
Journal:  J Comp Neurol       Date:  2007-04-01       Impact factor: 3.215

8.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

Review 9.  Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Authors:  Martine Perrot-Applanat; Melanie Di Benedetto
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

10.  Correlation between semaphorin3A-induced facilitation of axonal transport and local activation of a translation initiation factor eukaryotic translation initiation factor 4E.

Authors:  Chanxia Li; Yukio Sasaki; Kohtaro Takei; Hiroshi Yamamoto; Masayuki Shouji; Yoshinobu Sugiyama; Tadashi Kawakami; Fumio Nakamura; Takeshi Yagi; Toshio Ohshima; Yoshio Goshima
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.